Related Experiment Video
Updated: Jun 18, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Cardiac involvement in systemic sclerosis: A critical review of knowledge gaps and opportunities
Xaviar M Jones1, Nunzio Bottini2, Francesco Boin2
1Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Insights
Systemic sclerosis (SSc) can cause heart complications in up to 30% of patients. This review covers SSc cardiac disease mechanisms, diagnostics, and treatments to improve patient outcomes.
Area of Science:
- Cardiology
- Rheumatology
- Molecular Biology
Background:
- Systemic sclerosis (SSc) frequently leads to cardiovascular complications, affecting up to one-third of patients.
- Early diagnosis and management of SSc-associated cardiac disease are hindered by complex pathophysiology and varied presentations.
Purpose of the Study:
- To review the molecular mechanisms underlying SSc-associated cardiac disease.
- To discuss novel diagnostic tools for early identification.
- To explore emerging therapeutic strategies for SSc cardiac involvement.
Main Methods:
- Literature review of molecular mechanisms in SSc cardiac pathogenesis.
- Analysis of current and emerging diagnostic modalities.
- Survey of novel and experimental therapeutic approaches.
Main Results:
- Detailed examination of molecular pathways contributing to SSc cardiac dysfunction.
- Highlighting advancements in diagnostic imaging and biomarkers.
- Identification of promising therapeutic targets and treatments.
Conclusions:
- Understanding molecular mechanisms is crucial for managing SSc cardiac disease.
- Novel diagnostics offer improved early detection capabilities.
- Emerging therapies hold promise for better patient outcomes in SSc-associated heart conditions.
Abstract:
Cardiovascular complications are observed in up to one-third of patients with systemic sclerosis (SSc). Early identification and management of SSc-associated primary cardiac disease is often challenging, given the complex disease pathophysiology, significant variability in clinical presentation, and scarce disease-modifying therapeutics. Here, we review the molecular mechanisms involved in SSc-associated cardiac disease pathogenesis, novel diagnostic tools and emerging therapies.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy

